Drug Profile
Histamine dihydrochloride topical - EpiCept Corporation
Alternative Names: MaxDerm; MaxDerm gel; MX 1006; MX 8899Latest Information Update: 24 Oct 2021
Price :
$50
*
At a glance
- Originator Maxim Pharmaceuticals
- Class Antiepileptic drugs; Antimigraines; Antineoplastics; Antiparkinsonians; Antipsychotics; Antivirals; Behavioural disorder therapies; Ethylamines; Imidazoles; Neuroprotectants; Small molecules
- Mechanism of Action Apoptosis inhibitors; Histamine H2 receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Burns; Conjunctivitis; Herpes simplex virus infections; Herpes zoster; Pressure ulcer; Radiodermatitis; Stomatitis
Most Recent Events
- 09 Jan 2006 Maxim Pharmaceuticals has been acquired and merged into EpiCept Corporation
- 01 Mar 2004 Phase-II clinical trials in Burns in USA (Topical)
- 01 Mar 2004 Phase-II clinical trials in Conjunctivitis in USA (Topical)